Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 2 (2005), Issue 4 (April)

1. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases.
   Ophthalmologica, 219(2): 107-11. [Abstract] [Full-text]
2. Optical coherence tomographic assessment of diabetic macular edema: comparison with fluorescein angiographic and clinical findings.
   Ophthalmologica, 219(2): 86-92. [Abstract] [Full-text]
3. Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trial.
   Obstet Gynecol, 105(4): 811-5. [Abstract] [Full-text]
4. Japanese standard reference material JDS Lot 2 for haemoglobin A1c. II: Present state of standardization of haemoglobin A1c in Japan using the new reference material in routine clinical assays.
   Ann Clin Biochem, 42: 47-50. [Abstract] [Full-text]
5. Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: Comparison of Japan Diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories.
   Ann Clin Biochem, 42: 41-6. [Abstract] [Full-text]
6. Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin products.
   Curr Med Res Opin, 21(2): 291-8. [Abstract] [Full-text]
7. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004).
   Curr Med Res Opin, 21(2): 173-84. [Abstract] [Full-text]
8. Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia.
   J Med Chem, 48(7): 2262-5. [Abstract] [Full-text]
9. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus.
   Eur J Clin Nutr, 59(4): 592-6. [Abstract] [Full-text]
10. Fibrous proliferation of the pre-papillary canal in proliferative diabetic retinopathy: Cloquet's canal as a scaffold for proliferative diabetic retinopathy.
    Graefes Arch Clin Exp Ophthalmol, 243(3): 204-9. [Abstract] [Full-text]
11. Syngeneic islet transplantation into seminal vesicles of diabetic rats.
    J Invest Surg, 18(1): 13-8. [Abstract] [Full-text]
12. A fuzzy logic based closed-loop control system for blood glucose level regulation in diabetics.
    J Med Eng Technol, 29(2): 64-9. [Abstract] [Full-text]
13. Gestational diabetes exhibits lack of carnitine deficiency despite relatively low carnitine levels and alterations in ketogenesis.
    J Matern Fetal Neonatal Med, 17(1): 63-8. [Abstract] [Full-text]
14. Intraretinal pH in diabetic cats.
    Curr Eye Res, 30(3): 229-40. [Abstract] [Full-text]
15. Age at menarche, abnormal glucose tolerance and type 2 diabetes mellitus: The Rancho Bernardo Study.
    Climacteric, 8(1): 76-82. [Abstract] [Full-text]
16. Heart rate variability analysis: a useful assessment tool for diabetes associated cardiac dysfunction in rural and remote areas.
    Aust J Rural Health, 13(2): 77-82. [Abstract] [Full-text]
17. Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies.
    Eur J Neurol, 12(4): 294-9. [Abstract] [Full-text]
18. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms.
    Am J Hum Genet, 76(5): 773-9. [Abstract] [Full-text]
19. Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products.
    Br J Pharmacol, 144(7): 953-60. [Abstract] [Full-text]
20. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
    J Biol Chem, 280(14): 14105-13. [Abstract] [Full-text]
21. Progression of diabetic retinopathy during improved metabolic control may be treated with reduced insulin dosage and/or somatostatin analogue administration -- a case report.
    Growth Horm IGF Res, 15(2): 130-5. [Abstract] [Full-text]
22. Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats.
    Life Sci, 76(24): 2827-39. [Abstract] [Full-text]
23. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.
    Trends Endocrinol Metab, 16(3): 120-6. [Abstract] [Full-text]
24. Ovarian follicular lipoapoptosis: structural, cytochemical and metabolic basis of reproductive tract atrophy following expression of the hypogonadal diabetes (db/db) syndrome.
    Reprod Toxicol, 20(1): 31-8. [Abstract] [Full-text]
25. Psychosocial aspects of xenotransplantation: survey in adolescent recipients of porcine islet cells.
    Transplant Proc, 37(1): 521-4. [Abstract] [Full-text]
26. Xenotransplantation of neonatal porcine islets and Sertoli cells into nonimmunosuppressed streptozotocin-induced diabetic rats.
    Transplant Proc, 37(1): 470-1. [Abstract] [Full-text]
27. Enhancing islet engraftment with rosiglitazone.
    Transplant Proc, 37(1): 245-7. [Abstract] [Full-text]
28. Beneficial effects of pancreas transplantation: regeneration of pancreatic islets in the spontaneously diabetic Torii rat.
    Transplant Proc, 37(1): 226-8. [Abstract] [Full-text]
29. Independent association between leptin and blood pressure during third trimester in normal and gestational diabetic pregnancies.
    Eur J Obstet Gynecol Reprod Biol, 119(2): 180-4. [Abstract] [Full-text]
30. The role of mitochondrial DNA in the development of type 2 diabetes caused by fetal malnutrition.
    J Nutr Biochem, 16(4): 195-204. [Abstract] [Full-text]
31. Epiretinal pathology of diffuse diabetic macular edema associated with vitreomacular traction.
    Am J Ophthalmol, 139(4): 638-52. [Abstract] [Full-text]
32. Intraobserver repeatability of macula measurements by confocal scanning laser tomography.
    Am J Ophthalmol, 139(4): 624-30. [Abstract] [Full-text]
33. Persistent diabetic macular edema is associated with elevated hemoglobin A1c.
    Am J Ophthalmol, 139(4): 620-3. [Abstract] [Full-text]
34. A telemedicine program for diabetic retinopathy in a Veterans Affairs Medical Center--the Joslin Vision Network Eye Health Care Model.
    Am J Ophthalmol, 139(4): 597-604. [Abstract] [Full-text]
35. Effect of N-benzoyl-D-phenylalanine on streptozotocin-induced changes in the lipid and lipoprotein profile in rats.
    J Pharm Pharmacol, 57(3): 359-66. [Abstract] [Full-text]
36. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    J Pharm Pharmacol, 57(3): 317-25. [Abstract] [Full-text]
37. Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study.
    Clin Endocrinol (Oxf), 62(4): 480-6. [Abstract] [Full-text]
38. Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) in cynomolgus monkeys.
    Xenotransplantation, 12(3): 209-16. [Abstract] [Full-text]
39. Effect of glucose toxicity on intraportal tilapia islet xenotransplantation in nude mice.
    Xenotransplantation, 12(3): 189-96. [Abstract] [Full-text]
40. Reluctance of French patients with type 1 diabetes to undergo pig pancreatic islet xenotransplantation.
    Xenotransplantation, 12(3): 175-80. [Abstract] [Full-text]
41. Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin.
    Biopharm Drug Dispos, 26(3): 93-8. [Abstract] [Full-text]
42. Early infant diet and risk of type 1 diabetes mellitus in Belgrade children.
    Nutrition, 21(4): 474-9. [Abstract] [Full-text]
43. Quantitative effect of glycaemic improvement on the components of diabetic dyslipidaemia: a longitudinal study.
    Diabetes Res Clin Pract, 68(1): 81-3. [Abstract] [Full-text]
44. Central pontine and extrapontine myelinolysis associated with type 2 diabetic patient with hypokalemia.
    Diabetes Res Clin Pract, 68(1): 75-80. [Abstract] [Full-text]
45. Metabolic improvement after intervention focusing on personal understanding in type 2 diabetes.
    Diabetes Res Clin Pract, 68(1): 65-74. [Abstract] [Full-text]
46. Frequency and perceived burden of diabetes self-management activities in employees with insulin-treated diabetes: relationships with health outcomes.
    Diabetes Res Clin Pract, 68(1): 56-64. [Abstract] [Full-text]
47. Clinical characteristics at onset of Type 1 diabetes in children diagnosed between 1977 and 2001 in the south-east region of Sweden.
    Diabetes Res Clin Pract, 68(1): 49-55. [Abstract] [Full-text]
48. The haplotypes of the IRS-2 gene affect insulin sensitivity in Japanese patients with type 2 diabetes.
    Diabetes Res Clin Pract, 68(1): 39-48. [Abstract] [Full-text]
49. Short-term oral ingestion of Ginkgo biloba extract (EGb 761) reduces malondialdehyde levels in washed platelets of type 2 diabetic subjects.
    Diabetes Res Clin Pract, 68(1): 29-38. [Abstract] [Full-text]
50. Lifestyle modification improves risk factors in type 2 diabetes relatives.
    Diabetes Res Clin Pract, 68(1): 18-28. [Abstract] [Full-text]
51. Pressure response to carotid occlusion in diabetic rats: effect of insulin therapy.
    Diabetes Res Clin Pract, 68(1): 12-7. [Abstract] [Full-text]
52. Effect of Sanguis draxonis (a Chinese traditional herb) on the formation of insulin resistance in rats.
    Diabetes Res Clin Pract, 68(1): 3-11. [Abstract] [Full-text]
53. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Clin Ther, 27(2): 166-73. [Abstract] [Full-text]
54. CARDS on the table: should everybody with type 2 diabetes take a statin?
    Curr Med Res Opin, 21(3): 357-62. [Abstract] [Full-text]
55. Outcome studies in type 2 diabetes.
    Curr Med Res Opin, 21: S41-8. [Abstract] [Full-text]
56. Diabetic dyslipidaemia: insights for optimizing patient management.
    Curr Med Res Opin, 21: S29-40. [Abstract] [Full-text]
57. Diabetes and cardiovascular risk markers.
    Curr Med Res Opin, 21: S21-8. [Abstract] [Full-text]
58. Inflammatory, atherothrombotic aspects of type 2 diabetes.
    Curr Med Res Opin, 21: S5-12. [Abstract] [Full-text]
59. Introduction: the role of the thiazolidinediones in the cardiovascular risk management of type 2 diabetes.
    Curr Med Res Opin, 21: S1-3. [Abstract] [Full-text]
60. Lipoic acid prevents collagen abnormalities in tail tendon of high-fructose-fed rats.
    Diabetes Obes Metab, 7(3): 294-7. [Abstract] [Full-text]
61. Predictors of glycaemic control in indigent patients presenting with diabetic ketoacidosis.
    Diabetes Obes Metab, 7(3): 282-9. [Abstract] [Full-text]
62. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
    Diabetes Obes Metab, 7(3): 273-81. [Abstract] [Full-text]
63. Clinical implications of N epsilon-(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes.
    Diabetes Obes Metab, 7(3): 263-7. [Abstract] [Full-text]
64. Newly diagnosed childhood diabetes: a psychosocial transition for parents?
    J Adv Nurs, 50(3): 253-61. [Abstract] [Full-text]
65. New strategies in insulin treatment: analogues and noninvasive routes of administration.
    Fundam Clin Pharmacol, 19(2): 127-32. [Abstract] [Full-text]
66. The care of children and adolescents with type 2 diabetes.
    J Pediatr Nurs, 20(2): 96-106; quiz 107-8. [Abstract] [Full-text]
67. Education and telephone case management for children with type 1 diabetes: a randomized controlled trial.
    J Pediatr Nurs, 20(2): 83-95. [Abstract] [Full-text]
68. A cohort study of the impact of a national disease management program on HEDIS diabetes outcomes.
    Dis Manag, 8(2): 86-92. [Abstract] [Full-text]
69. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
    Nephrol Dial Transplant, 20: ii3-10, ii62. [Abstract] [Full-text]
70. Rejection after simultaneous pancreas-kidney transplantation.
    Nephrol Dial Transplant, 20: ii11-7, ii62. [Abstract] [Full-text]
71. Hypolipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats.
    J Ethnopharmacol, 98(3): 345-50. [Abstract] [Full-text]
72. Effects of wild ginseng (Panax ginseng C.A. Meyer) leaves on lipid peroxidation levels and antioxidant enzyme activities in streptozotocin diabetic rats.
    J Ethnopharmacol, 98(3): 245-50. [Abstract] [Full-text]
73. Investigation of lectin-modified insulin liposomes as carriers for oral administration.
    Int J Pharm, 294(1): 247-59. [Abstract] [Full-text]
74. Evaluation of drug therapy and risk factors in diabetic hypertensives: a study of the quality of care provided in diabetic clinics in Bahrain.
    J Eval Clin Pract, 11(2): 121-31. [Abstract] [Full-text]
75. Plasmid-electroporated primary hepatocytes acquire quasi-physiological secretion of human insulin and restore euglycemia in diabetic mice.
    Gene Ther, 12(8): 655-67. [Abstract] [Full-text]
76. Suppression of hepatic cholesteryl ester transfer protein expression in obese humans with the development of type 2 diabetes mellitus.
    J Clin Endocrinol Metab, 90(4): 2250-8. [Abstract] [Full-text]
77. Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes.
    J Clin Endocrinol Metab, 90(4): 1986-91. [Abstract] [Full-text]
78. Takayasu's arteritis and chronic autoimmune thyroiditis in a patient with type 1 diabetes mellitus.
    Clin Rheumatol, 24(2): 169-71. [Abstract] [Full-text]
79. Dichotomous responses of inter and postprandial hyperglycaemia to short-term calorie restriction in patients with type 2 diabetes.
    Eur J Clin Invest, 35(4): 259-64. [Abstract] [Full-text]
80. Early diabetes-related complications in adolescents: risk factors and screening.
    Horm Res, 63(2): 75-85. [Abstract] [Full-text]
81. Changes in aorta alpha1-adrenoceptor number and affinity during one year of streptozotocin-induced diabetes in rats.
    Pharmacology, 74(1): 23-30. [Abstract] [Full-text]
82. Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats.
    J Biol Inorg Chem, 10(2): 119-30. [Abstract] [Full-text]
83. Restless legs syndrome and sleep problems in children and adolescents with insulin-dependent diabetes mellitus type 1.
    Neuropediatrics, 36(2): 98-103. [Abstract] [Full-text]
84. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
    Eur J Nucl Med Mol Imaging, 32(4): 438-42. [Abstract] [Full-text]
85. Hypothesis for the pathogenesis of type 1A diabetes.
    Drugs Today (Barc), 41(2): 141-9. [Abstract] [Full-text]
86. Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats.
    J Mol Endocrinol, 34(2): 299-315. [Abstract] [Full-text]
87. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
    J Pain, 6(4): 253-60. [Abstract] [Full-text]
88. Mutation analysis of the preproghrelin gene: no association with obesity and type 2 diabetes.
    Clin Biochem, 38(5): 420-4. [Abstract] [Full-text]
89. Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes.
    Clin Biochem, 38(5): 415-9. [Abstract] [Full-text]
90. Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects.
    Clin Chim Acta, 355(1): 165-72. [Abstract] [Full-text]
91. Identification of candidate genes in the type 2 diabetes modifier locus using expression QTL.
    Genomics, 85(5): 591-9. [Abstract] [Full-text]
92. Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK).
    Int J Cardiol, 100(1): 79-84. [Abstract] [Full-text]
93. Effects of pancreas-kidney transplantation on diabetic retinopathy.
    Transpl Int, 18(5): 619-22. [Abstract] [Full-text]
94. A crucial role of MafA as a novel therapeutic target for diabetes.
    J Biol Chem, 280(15): 15047-52. [Abstract] [Full-text]
95. Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus.
    Am J Physiol Renal Physiol, 288(5): F1053-68. [Abstract] [Full-text]
96. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts.
    Am J Physiol Endocrinol Metab, 288(5): E900-6. [Abstract] [Full-text]
97. Regulation of adiponectin receptor gene expression in diabetic mice.
    Am J Physiol Endocrinol Metab, 288(5): E876-82. [Abstract] [Full-text]
98. Insensitivity to the alpha2-adrenergic receptor blocker yohimbine hydrochloride and occurrence of spontaneous platelet macroaggregation (SPMA) in diabetes.
    Platelets, 16(2): 111-5. [Abstract] [Full-text]
99. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
    Clin Ther, 26(12): 2066-75. [Abstract] [Full-text]
100. Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy.
     Clin Ther, 26(12): 2034-44. [Abstract] [Full-text]
101. Metabolic risk during antipsychotic treatment.
     Clin Ther, 26(12): 1936-46. [Abstract] [Full-text]
102. Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients.
     Med Hypotheses, 64(6): 1208-10. [Abstract] [Full-text]
103. Prevalence and characteristics of diabetic patients in a chronic heart failure population.
     Int J Cardiol, 100(2): 281-7. [Abstract] [Full-text]
104. Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation.
     Placenta, 26(4): 339-48. [Abstract] [Full-text]
105. Metabolic implications of obesity: before and after gastric bypass.
     Gastroenterol Clin North Am, 34(1): 9-24. [Abstract] [Full-text]
106. Type 2 diabetes: principles of pathogenesis and therapy.
     Lancet, 365(9467): 1333-46. [Abstract] [Full-text]
107. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis.
     Atherosclerosis, 180(1): 113-8. [Abstract] [Full-text]
108. Diabetes-related antibodies in adult diabetic patients.
     Best Pract Res Clin Endocrinol Metab, 19(1): 119-33. [Abstract] [Full-text]
109. Diabetes-related antibodies in euglycemic subjects.
     Best Pract Res Clin Endocrinol Metab, 19(1): 101-17. [Abstract] [Full-text]
110. Axonal potassium conductance and glycemic control in human diabetic nerves.
     Clin Neurophysiol, 116(5): 1181-7. [Abstract] [Full-text]
111. 5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes.
     J Physiol, 564: 563-73. [Abstract] [Full-text]
112. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
     J Autoimmun, 24(2): 153-67. [Abstract] [Full-text]
113. G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse.
     J Autoimmun, 24(2): 125-34. [Abstract] [Full-text]
114. Haemoglobin A1c: evaluation of three point of care analysers for use in a paediatric diabetes clinic.
     Ann Clin Biochem, 42: 124-9. [Abstract] [Full-text]
115. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
     Ann Clin Biochem, 42: 99-104. [Abstract] [Full-text]
116. Online diabetes education: design and evaluation with prospective diabetes camp counsellors.
     J Telemed Telecare, 11(2): 93-6. [Abstract] [Full-text]
117. Hyaluronic acid production and CD44 expression in cultured dermal fibroblasts of patients with non-insulin-dependent diabetes mellitus with and without chronic ulcers on the lower extremity.
     Wound Repair Regen, 13(2): 181-8. [Abstract] [Full-text]
118. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation.
     Ther Apher Dial, 9(1): 59-63. [Abstract] [Full-text]
119. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth.
     Mol Cell Biol, 25(9): 3752-62. [Abstract] [Full-text]
120. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.
     Mol Cell Biol, 25(9): 3620-9. [Abstract] [Full-text]
121. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
     Am J Hypertens, 18(4): 557-65. [Abstract] [Full-text]
122. Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats.
     Am J Hypertens, 18(4): 544-8. [Abstract] [Full-text]
123. Management of soft tissue deficiency of the hallux: salvage in trauma, diabetes, and following surgical complications.
     Foot Ankle Clin, 10(1): 55-74. [Abstract] [Full-text]
124. Heart failure in diabetes mellitus: clinical features and prognostic implications.
     Cardiology, 103(3): 161-6. [Abstract] [Full-text]
125. Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice.
     Nephrol Dial Transplant, 20(5): 879-85. [Abstract] [Full-text]
126. Orlistat in responding obese type 2 diabetic patients: meta-analysis findings and cost-effectiveness as rationales for reimbursement in Sweden and Switzerland.
     Int J Obes (Lond), 29(5): 517-23. [Abstract] [Full-text]
127. Assessment of nutritional intake, body mass index and glycemic control in patients with type-2 diabetes from northern Tanzania.
     Ann Nutr Metab, 49(1): 64-8. [Abstract] [Full-text]
128. Altered neurotrophism in diabetic neuropathy: spelunking the caves of peripheral nerve.
     J Pharmacol Exp Ther, 313(2): 485-91. [Abstract] [Full-text]
129. Cross-spectral analysis of cardiovascular variables in supine diabetic patients.
     Clin Auton Res, 15(2): 92-8. [Abstract] [Full-text]
130. Evaluation of time-course changes of gingival crevicular fluid glucose levels in diabetics.
     Biomed Microdevices, 7(1): 53-8. [Abstract] [Full-text]
131. In vitro and in vivo characterization of MEMS microneedles.
     Biomed Microdevices, 7(1): 47-52. [Abstract] [Full-text]
132. Diabetic thoracic polyradiculopathy.
     Best Pract Res Clin Gastroenterol, 19(2): 275-81. [Abstract] [Full-text]
133. Multifocal motor neuropathy, type 1 diabetes and asymptomatic Hashimoto's thyroiditis: an unusual association.
     Neuromuscul Disord, 15(5): 358-60. [Abstract] [Full-text]
134. Sodium orthovanadate exerts influence on liver Golgi complexes from control and streptozotocin-diabetic rats.
     J Inorg Biochem, 99(5): 1083-9. [Abstract] [Full-text]
135. Pharmacodynamics and pharmacokinetics of the insulin-mimetic agent vanadyl acetylacetonate in non-diabetic and diabetic rats.
     J Inorg Biochem, 99(5): 1064-75. [Abstract] [Full-text]
136. Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes.
     Diabetologia, 48(4): 616-20. [Abstract] [Full-text]
137. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
     Diabetologia, 48(4): 703-8. [Abstract] [Full-text]
138. High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes.
     Diabetologia, 48(4): 732-40. [Abstract] [Full-text]
139. Gene expression profiling of diabetic and galactosaemic cataractous rat lens by microarray analysis.
     Diabetologia, 48(4): 790-8. [Abstract] [Full-text]
140. Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients.
     Diabetologia, 48(4): 741-7. [Abstract] [Full-text]
141. Prospective incidence study of diabetes mellitus in New Zealand children aged 0 to 14 years.
     Diabetologia, 48(4): 643-8. [Abstract] [Full-text]
142. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes.
     Diabetologia, 48(4): 776-9. [Abstract] [Full-text]
143. Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.
     Diabetologia, 48(4): 784-9. [Abstract] [Full-text]
144. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats.
     Diabetologia, 48(4): 767-75. [Abstract] [Full-text]
145. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.
     Diabetologia, 48(4): 687-94. [Abstract] [Full-text]
146. Increased aortic stiffness is persistent in type 1 diabetic women: a follow-up study.
     Diabetologia, 48(4): 780-3. [Abstract] [Full-text]
147. Fat distribution is strongly associated with plasma glucose levels and diabetes in Thai adults-the InterASIA study.
     Diabetologia, 48(4): 657-60. [Abstract] [Full-text]
148. Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
     Diabetologia, 48(4): 695-702. [Abstract] [Full-text]
149. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases.
     Jpn J Ophthalmol, 49(2): 106-8. [Abstract] [Full-text]
150. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.
     J Exp Med, 201(8): 1333-46. [Abstract] [Full-text]
151. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
     Am J Hypertens, 18(4): 95S-99S. [Abstract] [Full-text]
152. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
     Contemp Clin Trials, 26(1): 17-24. [Abstract] [Full-text]
153. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.
     J Am Coll Cardiol, 45(8): 1172-9. [Abstract] [Full-text]
154. Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.
     Pain, 115(1): 29-36. [Abstract] [Full-text]
155. Computed tomography to visualize and quantify the plantar aponeurosis and flexor hallucis longus tendon in the diabetic foot.
     Clin Biomech (Bristol, Avon), 20(5): 540-6. [Abstract] [Full-text]
156. Does the thickening of Achilles tendon and plantar fascia contribute to the alteration of diabetic foot loading?
     Clin Biomech (Bristol, Avon), 20(5): 532-9. [Abstract] [Full-text]
157. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
     J Intern Med, 257(5): 446-53. [Abstract] [Full-text]
158. Lymphocytic hypophysitis: a rare cause of hypoglycaemia in a man with type 2 diabetes mellitus.
     Intern Med J, 35(4): 254-7. [Abstract] [Full-text]
159. A study of the prevalence of significant increases in serum creatinine following angiotension-converting enzyme inhibitor administration.
     J Hum Hypertens, 19(5): 389-92. [Abstract] [Full-text]
160. Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study.
     Ann Epidemiol, 15(5): 390-7. [Abstract] [Full-text]
161. Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models.
     Eur J Pharmacol, 512(2): 239-46. [Abstract] [Full-text]
162. Adolescents' and their parents' views on the acceptability and design of a new diabetes education programme: a focus group analysis.
     Child Care Health Dev, 31(3): 283-9. [Abstract] [Full-text]
163. Circulating vitamin E, transforming growth factor beta1, and the association with renal disease susceptibility in two racial groups with type 2 diabetes.
     Kidney Int, 67(5): 1993-8. [Abstract] [Full-text]
164. Effects of NADPH oxidase inhibitor in diabetic nephropathy.
     Kidney Int, 67(5): 1890-8. [Abstract] [Full-text]
165. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
     Kidney Int, 67(5): 1762-71. [Abstract] [Full-text]
166. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?
     Kidney Int, 67(5): 1684-91. [Abstract] [Full-text]
167. Recognizing the risk of erectile dysfunction in a urology clinic practice.
     BJU Int, 95(7): 1034-8. [Abstract] [Full-text]
168. Diabetes and chronic nitrate therapy as co-determinants of somatic DNA damage in patients with coronary artery disease.
     J Mol Med, 83(4): 279-86. [Abstract] [Full-text]
169. Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors.
     Am J Physiol Heart Circ Physiol, 288(5): H2154-62. [Abstract] [Full-text]
170. Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats.
     Am J Physiol Heart Circ Physiol, 288(5): H2210-8. [Abstract] [Full-text]
171. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats.
     Am J Physiol Heart Circ Physiol, 288(5): H2102-10. [Abstract] [Full-text]
172. Structural-tridimensional study of yolk sac in pregnancies complicated by diabetes.
     J Perinat Med, 33(2): 132-6. [Abstract] [Full-text]
173. Prognostic impact of diabetes mellitus in patients with acute decompensated heart failure.
     Am J Cardiol, 95(9): 1117-9. [Abstract] [Full-text]
174. Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients.
     Br J Clin Pharmacol, 59(5): 520-3. [Abstract] [Full-text]
175. Awareness and use of smoking cessation treatments among diabetic patients.
     Diabet Med, 22(5): 658-60. [Abstract] [Full-text]
176. Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes.
     Diabet Med, 22(5): 654-7. [Abstract] [Full-text]
177. Insights into the acute cerebral metabolic changes associated with childhood diabetes.
     Diabet Med, 22(5): 648-53. [Abstract] [Full-text]
178. Childhood diabetes presenting with hyperosmolar dehydration but without ketoacidosis: a report of three cases.
     Diabet Med, 22(5): 645-7. [Abstract] [Full-text]
179. A case of novel de novo paired box gene 6 (PAX6) mutation with early-onset diabetes mellitus and aniridia.
     Diabet Med, 22(5): 641-4. [Abstract] [Full-text]
180. Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial.
     Diabet Med, 22(5): 634-40. [Abstract] [Full-text]
181. Rodent bites on the feet of diabetes patients in Tanzania.
     Diabet Med, 22(5): 631-3. [Abstract] [Full-text]
182. Lifetime risk of symptomatic carpal tunnel syndrome in Type 1 diabetes.
     Diabet Med, 22(5): 625-30. [Abstract] [Full-text]
183. Changing patterns of primary care for diabetes in Trinidad and Tobago over 10 years.
     Diabet Med, 22(5): 619-24. [Abstract] [Full-text]
184. A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin.
     Diabet Med, 22(5): 612-8. [Abstract] [Full-text]
185. Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial.
     Diabet Med, 22(5): 606-11. [Abstract] [Full-text]
186. Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses.
     Diabet Med, 22(5): 590-8. [Abstract] [Full-text]
187. Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients.
     Diabet Med, 22(5): 583-9. [Abstract] [Full-text]
188. Effect of diabetes mellitus and its treatment on ventricular arrhythmias complicating acute myocardial infarction.
     Diabet Med, 22(5): 576-82. [Abstract] [Full-text]
189. Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population.
     Diabet Med, 22(5): 569-75. [Abstract] [Full-text]
190. Abnormal ventilatory responses to hypoxia in Type 2 diabetes.
     Diabet Med, 22(5): 563-8. [Abstract] [Full-text]
191. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
     Diabet Med, 22(5): 554-62. [Abstract] [Full-text]
192. Predictors of first stroke in Type 1 diabetes: The Fremantle Diabetes Study.
     Diabet Med, 22(5): 551-3. [Abstract] [Full-text]
193. Diabetes, hyperglycaemia and mortality in disabled older women: The Women's Health and Ageing Study I.
     Diabet Med, 22(5): 543-50. [Abstract] [Full-text]
194. Impact of hormone replacement therapy on microvascular function in healthy and Type 2 diabetic postmenopausal women.
     Diabet Med, 22(5): 536-42. [Abstract] [Full-text]
195. Genetics of Type 2 diabetes.
     Diabet Med, 22(5): 517-35. [Abstract] [Full-text]
196. Nurse follow-up of patients with diabetes: randomized controlled trial.
     J Adv Nurs, 50(4): 391-402. [Abstract] [Full-text]
197. Gianotti-Crosti syndrome in an adult following recent Mycoplasma pneumoniae infection.
     Australas J Dermatol, 46(2): 106-9. [Abstract] [Full-text]
198. Sulfasalazine and dermatitis herpetiformis.
     Australas J Dermatol, 46(2): 101-3. [Abstract] [Full-text]
199. Candidal overgrowth in diabetic patients: potential predisposing factors.
     Mycoses, 48(3): 192-6. [Abstract] [Full-text]
200. Inhaled insulin: Exubera.
     Ann Pharmacother, 39(5): 843-53. [Abstract] [Full-text]
201. Outcomes of Project Dulce: a culturally specific diabetes management program.
     Ann Pharmacother, 39(5): 817-22. [Abstract] [Full-text]
202. Long-term non-pharmacological weight loss interventions for adults with prediabetes.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
203. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
204. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
205. Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
206. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
207. Group based training for self-management strategies in people with type 2 diabetes mellitus.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
208. Screening for heart disease in diabetic subjects.
     Am Heart J, 149(2): 349-54. [Abstract] [Full-text]
209. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy.
     Am Heart J, 149(2): 329-35. [Abstract] [Full-text]
210. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study.
     Am Heart J, 149(2): e1-6. [Abstract] [Full-text]
211. Gestational diabetes: the consequences of not treating.
     Am J Obstet Gynecol, 192(4): 989-97. [Abstract] [Full-text]
212. Differences in the immediate effects of smoking on left ventricular diastolic function between healthy volunteers and patients with type 2 diabetes mellitus.
     J Am Soc Echocardiogr, 18(4): 320-5. [Abstract] [Full-text]
213. Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.
     J Endocrinol, 185(2): 307-17. [Abstract] [Full-text]
214. Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics.
     Anesth Analg, 100(5): 1241-7, table of contents. [Abstract] [Full-text]
215. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection.
     J Infect, 50(4): 331-7. [Abstract] [Full-text]
216. Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients.
     Biochem Biophys Res Commun, 331(1): 347-50. [Abstract] [Full-text]
217. Readmission patterns in patients with chronic obstructive pulmonary disease, chronic heart failure and diabetes mellitus: an administrative dataset analysis.
     Intern Med J, 35(5): 296-9. [Abstract] [Full-text]
218. Cranial magnetic resonance imaging of Wolfram (DIDMOAD) syndrome.
     Australas Radiol, 49(2): 189-91. [Abstract] [Full-text]
219. Altered nerve excitability properties in established diabetic neuropathy.
     Brain, 128: 1178-87. [Abstract] [Full-text]
220. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation.
     Transplant Proc, 37(2): 1326-7. [Abstract] [Full-text]
221. The standardization of pancreatic donors for islet isolation.
     Transplant Proc, 37(2): 1309-10. [Abstract] [Full-text]
222. Results from the inaugural year of the Collaborative Islet Transplant Registry.
     Transplant Proc, 37(2): 1305-8. [Abstract] [Full-text]
223. Pilot study of early corticosteroid elimination after pancreas transplantation.
     Transplant Proc, 37(2): 1287-8. [Abstract] [Full-text]
224. Comparable kidney graft survival of type 1 diabetics treated with simultaneous pancreas-kidney transplantation and nondiabetic patients treated with cadaveric renal transplantation.
     Transplant Proc, 37(2): 1285-6. [Abstract] [Full-text]
225. Simultaneous pancreas-kidney transplants in type I and type II diabetic patients with end-stage renal disease: similar 10-year outcomes.
     Transplant Proc, 37(2): 1283-4. [Abstract] [Full-text]
226. Successful solitary pancreas transplantation with portal-enteric drainage following unsuccessful islet cell transplantation.
     Transplant Proc, 37(2): 1278-9. [Abstract] [Full-text]
227. Ninety-five percent insulin independence rate 3 years after pancreas transplantation alone with portal-enteric drainage.
     Transplant Proc, 37(2): 1274-7. [Abstract] [Full-text]
228. Pancreas transplants from donors aged 45 years or older.
     Transplant Proc, 37(2): 1265-7. [Abstract] [Full-text]
229. Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation.
     Transplant Proc, 37(2): 1001-4. [Abstract] [Full-text]
230. Immediate conversion from tacrolimus to cyclosporine in the treatment of posttransplantation diabetes mellitus.
     Transplant Proc, 37(2): 999-1000. [Abstract] [Full-text]
231. Effect of race on the occurrence of posttransplant diabetes in kidney transplant recipients treated with early steroid discontinuation.
     Transplant Proc, 37(2): 819-21. [Abstract] [Full-text]
232. Evaluation of IDDM8 susceptibility locus in a Russian simplex family data set.
     J Autoimmun, 24(3): 243-50. [Abstract] [Full-text]
233. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients.
     Arch Med Res, 36(2): 159-65. [Abstract] [Full-text]
234. Impaired synthesis is not the reason for decreased activity of extracellular superoxide dismutase in patients with diabetes.
     Arch Med Res, 36(2): 148-53. [Abstract] [Full-text]
235. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
     Acta Physiol Scand, 184(1): 73-81. [Abstract] [Full-text]
236. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
     BMC Med Genet, 6: 11. [Abstract] [Full-text]
237. Association of sleep time with diabetes mellitus and impaired glucose tolerance.
     Arch Intern Med, 165(8): 863-7. [Abstract] [Full-text]
238. Diabetes care provision and glycaemic control in Northern Ireland: a UK regional audit.
     Arch Dis Child, 90(5): 468-73. [Abstract] [Full-text]
239. Effect of supplemental L-arginine on the function of T lymphocytes and the formation of advanced glycosylated end products in rats with streptozotocin-induced diabetes.
     Nutrition, 21(5): 615-23. [Abstract] [Full-text]
240. Evidence for Cd101 but not Fcgr1 as candidate for type 1 diabetes locus, Idd10.
     Biochem Biophys Res Commun, 331(2): 536-42. [Abstract] [Full-text]
241. No evidence for association of the TATA-box binding protein glutamine repeat sequence or the flanking chromosome 6q27 region with type 1 diabetes.
     Biochem Biophys Res Commun, 331(2): 435-41. [Abstract] [Full-text]
242. Plasma fatty acids of neonates born to mothers with and without gestational diabetes.
     Prostaglandins Leukot Essent Fatty Acids, 72(5): 335-41. [Abstract] [Full-text]
243. Hypoglycemic effect of crude exopolysaccharides produced by a medicinal mushroom Phellinus baumii in streptozotocin-induced diabetic rats.
     Life Sci, 76(26): 3069-80. [Abstract] [Full-text]
244. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.
     Am J Med, 118: 27S-34S. [Abstract] [Full-text]
245. Intensifying insulin therapy in patients with type 2 diabetes mellitus.
     Am J Med, 118: 21S-6S. [Abstract] [Full-text]
246. Making the transition from oral to insulin therapy.
     Am J Med, 118: 14S-20S. [Abstract] [Full-text]
247. How to select and combine oral agents for patients with type 2 diabetes mellitus.
     Am J Med, 118: 4S-13S. [Abstract] [Full-text]
248. A provisionally unique syndrome of macrosomia, bone overgrowth, macrocephaly, and tall stature.
     Am J Med Genet A, 134(4): 443-6. [Abstract] [Full-text]
249. Home blood glucose biosensors: a commercial perspective.
     Biosens Bioelectron, 20(12): 2435-53. [Abstract] [Full-text]
250. Upregulation of cyclooxygenase-II gene and PGE2 production of peritoneal macrophages in diabetic rats.
     J Surg Res, 125(2): 121-7. [Abstract] [Full-text]
251. Frequency of hepatitis G virus and transfusion-transmitted virus infection in type II diabetes mellitus.
     Int J Clin Pract, 59(2): 206-9. [Abstract] [Full-text]
252. Pioglitazone in a subgroup of patients with type 2 diabetes meeting the criteria for metabolic syndrome.
     Int J Clin Pract, 59(2): 134-42. [Abstract] [Full-text]
253. High-resolution genotyping of HLA-DQA1 in the GoKinD study and identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and HLA-DQA1*0404.
     Tissue Antigens, 65(5): 448-58. [Abstract] [Full-text]
254. Conflicts between young adolescents with type I diabetes and their parents.
     J Spec Pediatr Nurs, 10(2): 69-79; discussion 79-80. [Abstract] [Full-text]
255. Black and green teas equally inhibit diabetic cataracts in a streptozotocin-induced rat model of diabetes.
     J Agric Food Chem, 53(9): 3710-3. [Abstract] [Full-text]
256. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.
     Proc Natl Acad Sci U S A, 102(17): 6086-91. [Abstract] [Full-text]
257. Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes.
     Clin Chem, 51(5): 891-7. [Abstract] [Full-text]
258. Functional variants in SUMO4, TAB2, and NFkappaB and the risk of type 1 diabetes.
     Genes Immun, 6(3): 231-5. [Abstract] [Full-text]
259. Understanding why people with type 1 diabetes do not attend for specialist advice: a qualitative analysis of the views of people with insulin-dependent diabetes who do not attend diabetes clinic.
     J Health Psychol, 10(3): 409-23. [Abstract] [Full-text]
260. Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.
     J Pain Symptom Manage, 29(4): 401-10. [Abstract] [Full-text]
261. Differential effect of p75 neurotrophin receptor on expression of pro-apoptotic proteins c-jun, p38 and caspase-3 in dorsal root ganglion cells after axotomy in experimental diabetes.
     Neuroscience, 132(4): 1083-92. [Abstract] [Full-text]
262. A computational model to define the molecular causes of type 2 diabetes mellitus.
     Diabetes Technol Ther, 7(2): 323-36. [Abstract] [Full-text]
263. Memory of insulin pumps and their record as a source of information about insulin therapy in children and adolescents with type 1 diabetes.
     Diabetes Technol Ther, 7(2): 308-14. [Abstract] [Full-text]
264. Evaluation of a new blood glucose monitoring system with auto-calibration.
     Diabetes Technol Ther, 7(2): 283-94. [Abstract] [Full-text]
265. A graphical user interface for diabetes management that integrates glucose prediction and decision support.
     Diabetes Technol Ther, 7(2): 264-73. [Abstract] [Full-text]
266. A novel approach to continuous glucose analysis utilizing glycemic variation.
     Diabetes Technol Ther, 7(2): 253-63. [Abstract] [Full-text]
267. Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control.
     Diabetes Technol Ther, 7(2): 241-7. [Abstract] [Full-text]
268. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
     Diabetes Technol Ther, 7(2): 233-40. [Abstract] [Full-text]
269. Isoflavone supplements exert hormonal and antioxidant effects in postmenopausal Korean women with diabetic retinopathy.
     J Med Food, 8(1): 1-7. [Abstract] [Full-text]
270. Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
     J Med Chem, 48(9): 3141-52. [Abstract] [Full-text]
271. Maintenance of osseointegration utilizing insulin therapy in a diabetic rat model.
     J Periodontol, 76(4): 621-6. [Abstract] [Full-text]
272. Modulating the effects of diabetes on osseointegration with aminoguanidine and doxycycline.
     J Periodontol, 76(4): 614-20. [Abstract] [Full-text]
273. Diabetes and periodontal disease: a case-control study.
     J Periodontol, 76(3): 418-25. [Abstract] [Full-text]
274. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study.
     J Am Soc Nephrol, 16(5): 1404-12. [Abstract] [Full-text]
275. Statins and diabetes.
     Semin Vasc Med, 4(4): 321-32. [Abstract] [Full-text]
276. Many little things: one geneticist's view of complex diseases.
     Nat Rev Genet, 6(5): 419-25. [Abstract] [Full-text]
277. The role of distal arterial reconstruction in patients with diabetic foot ischemia.
     Int J Low Extrem Wounds, 4(1): 45-9. [Abstract] [Full-text]
278. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
     Trends Endocrinol Metab, 16(4): 190-7. [Abstract] [Full-text]
279. Cholesterol levels after 3 days of high-dose simvastatin in patients at moderate to high risk for coronary events.
     Int J Cardiol, 101(1): 111-4. [Abstract] [Full-text]
280. Oxidative stress and fibrosis in incipient myocardial dysfunction in type 2 diabetic patients.
     Int J Cardiol, 101(1): 53-8. [Abstract] [Full-text]
281. Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema.
     Am J Ophthalmol, 139(5): 807-13. [Abstract] [Full-text]
282. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone.
     Am J Ophthalmol, 139(5): 802-6. [Abstract] [Full-text]
283. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
     Am J Ophthalmol, 139(5): 795-801. [Abstract] [Full-text]
284. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion.
     Eur J Clin Invest, 35(5): 330-6. [Abstract] [Full-text]
285. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
     Eur J Clin Invest, 35(5): 324-9. [Abstract] [Full-text]
286. Diabetic brain damage in hypertension: role of renin-angiotensin system.
     Hypertension, 45(5): 887-93. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.